Effects of immune‐related adverse events ( irAEs ) and their treatment on antitumor immune responses

Immune checkpoint inhibitors (ICIs) are potentially life‐saving cancer therapies that can trigger immune‐related adverse events (irAEs). irAEs can impact any organ and range in their presentation from mild side effects to life‐threatening complications. The relationship between irAEs and antitumor i...

Full description

Saved in:
Bibliographic Details
Published in:Immunological reviews 2023-09, Vol.318 (1), p.167-178
Main Authors: Blum, Steven M., Rouhani, Sherin J., Sullivan, Ryan J.
Format: Article
Language:English
Subjects:
Adverse events
Anticancer properties
Antigen (tumor-associated)
Antigens
Antitumor activity
Cancer therapies
Histology
Immune checkpoint inhibitors
Immune response
Immune system
immunosuppression
Immunosuppressive agents
neoplasms
patients
Side effects
Therapeutic targets
therapeutics
Tumor cells
Tumor microenvironment
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!